Scott Cormack
2010
In 2010, Scott Cormack earned a total compensation of $1.1M as President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $214,078 |
|---|---|
| Option Awards | $453,600 |
| Salary | $475,825 |
| Total | $1,143,503 |
Cormack received $475.8K in salary, accounting for 42% of the total pay in 2010.
Cormack also received $214.1K in non-equity incentive plan and $453.6K in option awards.
Rankings
In 2010, Scott Cormack's compensation ranked 4,829th out of 10,439 executives tracked by ExecPay. In other words, Cormack earned more than 53.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,829 out of 10,439 | 54th |
Division Manufacturing | 1,729 out of 3,838 | 55th |
Major group Chemicals And Allied Products | 354 out of 921 | 62nd |
Industry group Drugs | 204 out of 680 | 70th |
Industry In Vitro and In Vivo Diagnostic Substances | 10 out of 51 | 80th |
Source: SEC filing on April 21, 2011.
Cormack's colleagues
We found three more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2010.